About Mt. Sinai Medical Center Division of Hematology/Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Mt. Sinai Medical Center Division of Hematology/Oncology
During the past decade, Mt. Sinai Medical Center Division of Hematology/Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases
2010-09-30
2015-06-30
Completed
210
An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE)
2012-03-05
2016-07-20
Completed
402
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice
2013-07-25
2018-03-20
Completed
279
An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer
2015-01-14
2016-11-10
Completed
510
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Mt. Sinai Medical Center Division of Hematology/Oncology"
#1 collaborator was "bluebird bio" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Mt. Sinai Medical Center Division of Hematology/Oncology
According to Clinical.Site data, the most researched conditions in "Mt. Sinai Medical Center Division of Hematology/Oncology" are
"Multiple Myeloma" (3 trials) and "Leukemia, Myeloid" (1 trials). Many other conditions were trialed in "Mt. Sinai Medical Center Division of Hematology/Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Mt. Sinai Medical Center Division of Hematology/Oncology
Most popular intervention types in "Mt. Sinai Medical Center Division of Hematology/Oncology" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone" (1 trials), "CC-92328" (1 trials), "CC-96191" (1 trials) and "bb2121" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mt. Sinai Medical Center Division of Hematology/Oncology
The vast majority of trials in "Mt. Sinai Medical Center Division of Hematology/Oncology" are
4 trials for "All" genders.
Clinical Trials Status at Mt. Sinai Medical Center Division of Hematology/Oncology
Currently, there are NaN active trials in "Mt. Sinai Medical Center Division of Hematology/Oncology".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Mt. Sinai Medical Center Division of Hematology/Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mt. Sinai Medical Center Division of Hematology/Oncology, 4 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".